CervoMed Inc. (CRVO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$1.98M2011: -$12.02M2012: -$4.31M2013: -$1.18M2014: -$9.03M2015: -$5.19M2016: -$10.77M2017: -$12.33M2018: -$10.77M2019: -$9.86M2020: -$13.55M2021: -$14.50M2022: -$2.57M2023: -$7.45M2024: -$16.53M2025: -$23.45M-$23.45M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$23.45M-41.9%
2024-$16.53M-121.9%
2023-$7.45M-189.6%
2022-$2.57M+82.3%
2021-$14.50M-7.0%
2020-$13.55M-37.5%
2019-$9.86M+8.5%
2018-$10.77M+12.6%
2017-$12.33M-14.5%
2016-$10.77M-107.7%
2015-$5.19M+42.6%
2014-$9.03M-662.3%
2013-$1.18M+72.5%
2012-$4.31M+64.2%
2011-$12.02M-507.0%
2010-$1.98M